Achieve Life Sciences, Inc. (ACHV) financial statements (2022 and earlier)

Company profile

Business Address 22722 29TH DR. SE
SEATTLE, WA 98021
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments43,02233,31242,00129,63735,85322,39312,111
Cash and cash equivalents43,02233,31242,00129,63735,85322,39312,111
Receivables153151     
Other undisclosed current assets1,4191,2704308021,1221,669545
Total current assets:44,59434,73342,43130,43936,97524,06212,656
Noncurrent Assets
Operating lease, right-of-use asset647994108146193240
Property, plant and equipment15212733425056
Intangible assets, net (including goodwill)2,6752,7312,7862,8432,8982,9543,010
Goodwill1,0341,0341,0341,0341,0341,0341,034
Intangible assets, net (excluding goodwill)1,6411,6971,7521,8091,8641,9201,976
Restricted cash and investments    505050
Other noncurrent assets    187308446
Other undisclosed noncurrent assets168235227239   
Total noncurrent assets:2,9223,0663,1343,2233,3233,5553,802
TOTAL ASSETS:47,51637,79945,56533,66240,29827,61716,458
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,1292,2501,5631,3182,3901,6261,572
Accounts payable841815575585332326523
Accrued liabilities348194193211584360314
Employee-related liabilities1,9401,2417955221,474940735
Other undisclosed current liabilities1,4218263,1072,197545222238
Total current liabilities:4,5503,0764,6703,5152,9351,8481,810
Noncurrent Liabilities
Long-term debt and lease obligation14,9242341597794110
Long-term debt, excluding current maturities14,920      
Operating lease, liability42341597794110
Other undisclosed noncurrent liabilities(4)(23)(41)(59)(77)(94)(110)
Total noncurrent liabilities:14,920234159 94110
Total liabilities:19,4743,0994,7113,5743,0121,9421,920
Stockholders' equity
Stockholders' equity attributable to parent28,04234,70040,85430,08837,28625,67514,538
Common stock79797976767451
Additional paid in capital121,545121,052120,51598,44197,64081,30766,429
Accumulated other comprehensive income4444444
Accumulated deficit(93,586)(86,435)(79,744)(68,433)(60,434)(55,710)(51,946)
Total stockholders' equity:28,04234,70040,85430,08837,28625,67514,538
TOTAL LIABILITIES AND EQUITY:47,51637,79945,56533,66240,29827,61716,458

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Operating expenses(7,127)(6,693)(11,302)(8,048)(4,730)(3,754)(2,918)
Operating loss:(7,127)(6,693)(11,302)(8,048)(4,730)(3,754)(2,918)
Nonoperating income (expense)(36)2(9)(15)(3)(10)(4)
Investment income, nonoperating33382223
Other nonoperating expense(39)(1)(12)(23)(25)(12)(7)
Loss from continuing operations before equity method investments, income taxes:(7,163)(6,691)(11,311)(8,063)(4,733)(3,764)(2,922)
Other undisclosed income from continuing operations before income taxes200      
Loss before gain (loss) on sale of properties:(6,963)(6,691)(11,311)(8,063)(4,733)(3,764)(2,922)
Other undisclosed net income (loss)(188)  649  
Net loss available to common stockholders, diluted:(7,151)(6,691)(11,311)(7,999)(4,724)(3,764)(2,922)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(7,151)(6,691)(11,311)(7,999)(4,724)(3,764)(2,922)
Comprehensive loss, net of tax, attributable to parent:(7,151)(6,691)(11,311)(7,999)(4,724)(3,764)(2,922)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: